TCGA data revealed a decrease in ARNT2 levels with higher glioma grades (Fig. 2C), a trend corroborated by analysis of the Chinese Glioma Genome Atlas (CGGA) (Figure S2I). This evidence concerns the gene ARNT2 and central nervous system cancer.